High Glucose-Induced Expression of Proinflammatory Cytokine and Chemokine Genes in Monocytic Cells (Q40652063)

22 September 2017

High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells (English)

1 reference

22 September 2017

High Glucose-Induced Expression of Proinflammatory Cytokine and Chemokine Genes in Monocytic Cells (English)

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

28 December 2023

author name string

Narkunaraja Shanmugam

1

1 reference

22 September 2017

Mausumee Guha

3

1 reference

22 September 2017

Rama Natarajan

4

1 reference

22 September 2017

Marpadga A. Reddy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716761

28 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

22 September 2017

1 reference

22 September 2017

52

1 reference

22 September 2017

1256-1264

1 reference

22 September 2017

5

1 reference

Glucose and diabetic vascular disease.

22 September 2017

1

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease

28 December 2023

2

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Oxidative stress and diabetic vascular complications

28 December 2023

4

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

28 December 2023

5

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

28 December 2023

6

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

New approaches for treatment in diabetes: aldose reductase inhibitors

28 December 2023

7

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus

28 December 2023

8

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

28 December 2023

9

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Interaction of diabetes and hypertension on determinants of endothelial adhesiveness.

28 December 2023

12

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro

28 December 2023

13

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion

28 December 2023

15

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways

28 December 2023

16

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

28 December 2023

17

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli

28 December 2023

18

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

28 December 2023

19

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Transcriptional regulation of chemokine gene expression in astrocytes

28 December 2023

20

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Elevated serum IP-10 levels observed in type 1 diabetes

28 December 2023

21

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response

28 December 2023

22

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

28 December 2023

23

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

28 December 2023

24

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo

28 December 2023

25

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Cloning of the beta subunit of the leukocyte adhesion proteins: homology to an extracellular matrix receptor defines a novel supergene family.

28 December 2023

26

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease

28 December 2023

27

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

28 December 2023

28

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

28 December 2023

29

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Structure of human tumor necrosis factor alpha derived from recombinant DNA

28 December 2023

30

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions

28 December 2023

33

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways

28 December 2023

34

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha

28 December 2023

35

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway

28 December 2023

39

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Interferon-stimulated response element and NF kappa B sites cooperate to regulate double-stranded RNA-induced transcription of the IP-10 gene.

28 December 2023

41

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma

28 December 2023

43

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

28 December 2023

44

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes.

28 December 2023

46

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

28 December 2023

47

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1256

28 December 2023

Identifiers

1 reference

22 September 2017

1 reference